These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

656 related items for PubMed ID: 11543655

  • 1. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
    Burioni R, Bugli F, Mancini N, Rosa D, Di Campli C, Moroncini G, Manzin A, Abrignani S, Varaldo PE, Clementi M, Fadda G.
    Virology; 2001 Sep 15; 288(1):29-35. PubMed ID: 11543655
    [Abstract] [Full Text] [Related]

  • 2. Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments.
    Burioni R, Plaisant P, Manzin A, Rosa D, Delli Carri V, Bugli F, Solforosi L, Abrignani S, Varaldo PE, Fadda G, Clementi M.
    Hepatology; 1998 Sep 15; 28(3):810-4. PubMed ID: 9731577
    [Abstract] [Full Text] [Related]

  • 3. Human antibodies from phage display libraries: expression of recombinant full length immunoglobulin G specific to the hepatitis C virus E2 glycoprotein.
    Bugli F, Graffeo R, Pescatori M, Paroni Sterbini F, Torelli R, Masucci L, Manzara S, Fadda G.
    New Microbiol; 2009 Oct 15; 32(4):341-9. PubMed ID: 20128440
    [Abstract] [Full Text] [Related]

  • 4. Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity.
    Schofield DJ, Bartosch B, Shimizu YK, Allander T, Alter HJ, Emerson SU, Cosset FL, Purcell RH.
    Hepatology; 2005 Nov 15; 42(5):1055-62. PubMed ID: 16250048
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.
    Mancini N, Canducci F, Carletti S, Berardinelli E, Serafini G, Grieco A, Perotti M, Malcangi G, Danieli MG, Varaldo PE, Clementi M, Burioni R.
    J Biol Regul Homeost Agents; 2003 Nov 15; 17(2):183-7. PubMed ID: 14518720
    [Abstract] [Full Text] [Related]

  • 7. Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.
    Burioni R, Mancini N, Carletti S, Perotti M, Grieco A, Canducci F, Varaldo PE, Clementi M.
    Virology; 2004 Oct 01; 327(2):242-8. PubMed ID: 15351212
    [Abstract] [Full Text] [Related]

  • 8. Fabs specific for 8-oxoguanine: control of DNA binding.
    Bespalov IA, Bond JP, Purmal AA, Wallace SS, Melamede RJ.
    J Mol Biol; 1999 Nov 12; 293(5):1085-95. PubMed ID: 10547287
    [Abstract] [Full Text] [Related]

  • 9. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library.
    Mink MA, Benichou S, Madaule P, Tiollais P, Prince AM, Inchauspe G.
    Virology; 1994 Apr 12; 200(1):246-55. PubMed ID: 7510436
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Preparation of human single chain Fv antibody specifically against hepatitis C virus E2 antigen].
    Zhong Y, Cheng J, Shi S, Wang G, Xia X, Tian X, Li L, Zhang L, Chen J.
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr 12; 10(2):109-11. PubMed ID: 11983126
    [Abstract] [Full Text] [Related]

  • 12. Internal images: human anti-idiotypic Fab antibodies mimic the IgE epitopes of grass pollen allergen Phl p 5a.
    Hantusch B, Knittelfelder R, Wallmann J, Krieger S, Szalai K, Untersmayr E, Vogel M, Stadler BM, Scheiner O, Boltz-Nitulescu G, Jensen-Jarolim E.
    Mol Immunol; 2006 Jul 12; 43(14):2180-7. PubMed ID: 16510185
    [Abstract] [Full Text] [Related]

  • 13. Generation of an HFRS patient-derived neutralizing recombinant antibody to Hantaan virus G1 protein and definition of the neutralizing domain.
    Liang M, Mahler M, Koch J, Ji Y, Li D, Schmaljohn C, Bautz EK.
    J Med Virol; 2003 Jan 12; 69(1):99-107. PubMed ID: 12436484
    [Abstract] [Full Text] [Related]

  • 14. Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein.
    Diotti RA, Sautto GA, Solforosi L, Mancini N, Clementi M, Burioni R.
    New Microbiol; 2012 Oct 12; 35(4):475-9. PubMed ID: 23109015
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
    Esumi M, Ahmed M, Zhou YH, Takahashi H, Shikata T.
    Virology; 1998 Nov 10; 251(1):158-64. PubMed ID: 9813211
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.